HAS Healthcare Advanced Synthesis SA, together with Cerbios-Pharma SA, forms a premier international group in the Contract Development Manufacturing Organization (CDMO) sector.

United by a shared commitment to innovation, quality, and family-owned values, the Group brings together over four decades of expertise in the development and production of Active Pharmaceutical Ingredients (APIs), Highly Potent APIs (HPAPIs), Anticancer compounds, and cutting-edge biological solutions including Antibody Drug Conjugates (ADCs).

Backed by 65 Equity Partners, this alliance strengthens our global presence and enhances our ability to deliver tailored, high-quality solutions across oncology, rare diseases, and other complex therapeutic areas while maintaining deep roots in Switzerland’s Ticino region.

HAS Healthcare Advanced Synthesis SA

HAS Healthcare Advanced Synthesis SA is a leading contract development and manufacturing organization (CDMO) located in Biasca, Switzerland

Cerbios-Pharma SA

Cerbios-Pharma SA is a leading contract development and manufacturing organization (CDMO) specializing in chemical and biological APIs, ADC headquartered in Barbengo-Lugano, Switzerland.

Proveo

Proveo™ is a Division of Cerbios-Pharma SA providing complete and efficient solutions for process development and manufacturing of Antibody Drug Conjugates (ADCs).

GMT Fine Chemicals SA

GMT Fine Chemicals SA is a Swiss-based contract development and manufacturing organization (CDMO) specializing in reduced folates and pharmaceutical APIs, located in Couvet, Switzerland.